The Korea Disease Control and Prevention Agency's National Institute of Health announced the creation of a Korean‑specific prognostic framework that divides Alzheimer’s disease progression risk into six distinct stages.
The model was derived from cohort data of elderly dementia patients in Korea, enabling clinicians to stratify patients' risk of disease advancement more precisely than by cognitive stage alone.
The research results have been published in the international journal Nature Communications, highlighting the potential of the new system to improve prediction and management of Alzheimer’s disease in the Korean population.
Nghiên cứu & Báo cáo30 thg 8, 2026•1 phút đọc
Korean Institute Develops 6‑Stage Prognostic System for Alzheimer’s Progression
Korea's National Institute of Health created a six‑stage risk model for Alzheimer’s disease progression using domestic elderly dementia cohort data, published in Nature Communications.
Tổng hợp bởi đội ngũ PharmaCountry · Nguồn: KPA News
Đánh giá
(0)
(0)
(0)
(0)
(0)
Bài viết khác
Xem tất cả bài viếtNghiên cứu & Báo cáo
Global Finished Dosage Manufacturing Landscape 2026
5 thg 10, 2026
Cập nhật pháp chếKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 thg 9, 2026
Phân tíchPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 thg 9, 2026
Để lại đánh giá